Co-Founder & CEO of MAIN ( MaQasid Angel Investor Network) & Chairman of ICG (İstanbul Consulting Group) , president of SoPE (Society of Physician Entrepreneur) Turkey, Dr. Yavuz Silay previously joined FasterCapital as a #regional partner from #Turkey with an incredible passion for accelerating healthcare, Biotech, energy, IT and finance entrepreneurs .He lived 7 years in Germany and 14 years in the USA. He recently founded the first private Hospital R&D center , Avcılar Hospital R&D center where Engineers and Physicians work together to improve patients life with innovative technologies in Turkey. He is also the Corporate Communication Director of Sumitomo Group/Expel İlaç and several other companies


Yavuz Selim Sılay MD, MBA Linkedin Profile

Co-Founder & CEO of MAIN ( MaQasid Angel Investor Network) & Chairman of Istanbul Consulting Group (ICG) -BioPharma CEO, Carveout, Turnaround Specialist
-Businessman, Entrepreneur Doctor & "International Healthcare Executive (Pharmaceutical, Diagnostic & Medical Device)", Management Consultant, "Business, Strategy, Marketing Savvy Physician
-Board member of WIHU ICG,SKYDER, BID,
-Previously Managed the largest distributor of Siemens Diagnostics in Turkey with ~220 employees
- Worked in USA as Vice President of Ipsen Pharmaceutical, Director at Teva, Associate Director at KV, Physician Scientist at Forest Pharmaceutical & Clinical Research Director at Baylor
- Team player, Silobuster,Get Things Done-
- Formerly Providing strategic guidance to the Research Based Pharmaceutical Companies & at The World Bank for ministry of health in the area of organ transplant , cell & tissue banking
- Proven ability to build high performing teams & productive organizations, turn around brands & build revenue in diverse markets

A value-driven leader with successful track record. Core Competencies include:

- Financial management & Leadership & Team Building
- Interpersonal Communication 
- Analytical Thinking 
- Crisis Management 
- Public Speaking
- Strategic Planning and Development
- Clinical development
- Medical Affairs
- Market Access
- Payer Strategy
- Innovation and entrepreneurialism
- New product development, commercialization & lifecycle management of existing products
- Business development
- Global Market Access
- P&L
- Change management and organizational design
- Talent recruitment, selection, and development

Interaction with FDA. Development of generic and branded regulatory strategic plans for new product development, life cycle management of marketed products
Evaluation of potential products & in-licensing opportunities
Participate in all aspects of clinical development & study management, providing scientific, medical, and logistical direction and support to studies.Clinical development in CNS/Pain
Managing Phase 2-4 clinical trials 
Submitting NDA/sNDA